HIGHLIGHTS
- who: Anders Kjellberg from the Prospective randomised, parallel arms, placebo-controlled, double blind, clinical trial at Karolinska University Hospital, SwedenWe plan to enroll , previously healthy subjects diagnosed with PCC (U09.9) randomised (1:1) to u00ad, or placebo (sham treatment), maximum ten treatments within , weeks from randomisation (Fig., ). , was administered at, ., Bar for , min with two five minutes have published the article: Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial, in the Journal: (JOURNAL) of 13/04/2021
- what: The aim of this interim analysis is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.